EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieKlinische Studie (Phase III)Multizentrische StudieOpen Access

Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity

Atul Malhotra, Ronald R Grunstein, Ingo Fietze, Terri E Weaver, Susan Redline, Ali Azarbarzin, Scott A Sands, Richard J Schwab, Julia P Dunn, Sujatro Chakladar, Mathijs C Bunck, Josef Bednarik und 1 weitere

New England Journal of Medicine · 03.10.2024 · 391 (13) · 1193-1205

DOI: 10.1056/nejmoa2404881 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 03.10.2024. Verfasst von Atul Malhotra und 12 weiteren Autor:innen. Beteiligte Einrichtung: From the University of California, San Diego, La Jolla (A.M.); Woolcock Institute of Medical Research, Macquarie University, Royal Prince Alfred Hosp…. Hauptthemen laut MEDLINE: Hypoxia, Obesity, Sleep Apnea, Obstructive, Gastric Inhibitory Polypeptide. Die Arbeit wurde bisher 907-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIA NIH HHS, Eli Lilly and Company.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypoxiaObesitySleep Apnea, ObstructiveGastric Inhibitory PolypeptideGlucagon-Like Peptide-1 Receptor AgonistsAdultFemaleHumansMaleMiddle AgedBlood PressureBody WeightC-Reactive ProteinDouble-Blind MethodSeverity of Illness IndexMaximum Tolerated DoseSleep QualityTreatment OutcomeTirzepatide

Substanzen

C-Reactive ProteinTirzepatideGastric Inhibitory PolypeptideGlucagon-Like Peptide-1 Receptor Agonists

Autor:innen und Institutionen

  • From the University of California, San Diego, La Jolla (A.M.); Woolcock Institute of Medical Research, Macquarie University, Royal Prince Alfred Hospital, and the University of Sydney - all in Sydney (R.R.G.); the Cente…

Förderung

  • NHLBI NIH HHS
  • NIA NIH HHS
  • Eli Lilly and Company

Zitieren

APA

Malhotra, A., Grunstein, R. R., Fietze, I., Weaver, T. E., Redline, S., Azarbarzin, A., Sands, S. A., Schwab, R. J., Dunn, J. P., Chakladar, S., Bunck, M. C., Bednarik, J., & SURMOUNT-OSA Investigators (2024). Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. New England Journal of Medicine, 391(13), 1193-1205. https://doi.org/10.1056/nejmoa2404881

Vancouver

Malhotra A, Grunstein RR, Fietze I, Weaver TE, Redline S, Azarbarzin A, et al. Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. New England Journal of Medicine. 2024;391(13):1193-1205. doi:10.1056/nejmoa2404881

BibTeX
@article{Malhotra2024,
  author = {Malhotra, Atul and Grunstein, Ronald R and Fietze, Ingo and Weaver, Terri E and Redline, Susan and Azarbarzin, Ali and Sands, Scott A and Schwab, Richard J and Dunn, Julia P and Chakladar, Sujatro and Bunck, Mathijs C and Bednarik, Josef and SURMOUNT-OSA Investigators, SURMOUNT-OSA Investigators},
  title = {Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity},
  journal = {New England Journal of Medicine},
  year = {2024},
  volume = {391},
  number = {13},
  pages = {1193--1205},
  doi = {10.1056/nejmoa2404881}
}
Kostenlos starten →